Advisory Services

Kokoro Consulting provides execution-focused leadership across external manufacturing, CMC strategy, and global supply operations.

We work with pharmaceutical organizations navigating high-risk transitions from development to commercial supply, with a focus on CDMO performance, governance, and supply reliability.

Engagements are focused where execution risk is high and experienced operational leadership is required.


  • Designing and managing external manufacturing networks to ensure reliable, scalable commercial supply.

    When we engage:

    • Preparing for commercial launch without established manufacturing infrastructure

    • Underperforming CDMO relationships impacting timelines or supply

    • Establishing governance, oversight, and performance management across global partners

    Core capabilities:

    • CDMO selection, evaluation, and onboarding strategy

    • Governance frameworks and operating models

    • Performance management and KPI development

    • Technical and operational oversight

    • Supply agreement strategy and negotiation

  • Leading CMC strategy and execution to transition products from development into reliable commercial supply.

    When we engage:

    • Transitioning from Phase 2/3 into commercial readiness

    • CMC strategy misaligned with commercial manufacturing requirements

    • Accelerated timelines requiring disciplined execution

    Core capabilities:

    • CMC strategy development and alignment

    • Development to commercial transition strategy and planning

    • Process validation strategy

    • Regulatory CMC strategy and execution

    • Cross-functional leadership across Quality, Regulatory, and Supply Chain

  • Executing technology transfers and ensuring readiness for reliable, sustained commercial supply.

    When we engage:

    • Transferring processes between CDMOs or from internal to external manufacturing networks

    • Preparing for commercial launch or scale-up execution

    • Delays or issues during transfer execution impacting timelines or supply

    Core capabilities:

    • Tech transfer planning and execution

    • Process scale-up and validation strategy and execution

    • Site readiness and operational alignment across manufacturing and quality functions

    • Transfer risk assessment and mitigation planning

    • Risk identification and mitigation

    • Troubleshooting during transfer execution and startup

  • Providing experienced operational leadership to drive manufacturing, CMC, and supply chain performance.

    When we engage:

    • Gaps in internal leadership across technical operations or supply chain

    • Need for experienced leadership during critical decision-making phases

    • Organizational scaling, restructuring, or operating model redesign

    Core capabilities:

    • Interim leadership across technical operations and supply chain

    • Strategic advisory to executive leadership teams

    • Organizational design and operating model development

    • Cross-functional leadership and alignment

    • Decision support during high-risk execution and commercialization

    • Building and leading technical operations organizations from the ground up

  • Providing investors with operational diligence and execution oversight across portfolio companies.

    When we engage:

    • Evaluating manufacturing scalability and risk pre- and post-investment

    • Portfolio companies lacking experienced technical operations or supply chain leadership

    • Identifying and mitigating manufacturing and supply chain risk

    Core capabilities:

    • Technical and operational due diligence

    • CDMO evaluation, governance assessment, and risk identification

    • Manufacturing scalability and readiness assessment

    • Portfolio company execution oversight and advisory

    • Value creation through operational improvement and supply chain performance

    • Rapid assessment and stabilization of at-risk manufacturing and supply operations

  • Stabilizing supply and restoring performance in underperforming manufacturing networks.

    When we engage:

    • Recurring deviations, batch failures, or persistent quality issues

    • Missed delivery timelines or sustained supply disruptions

    • Lack of clear root cause or ineffective remediation strategies

    Core capabilities:

    • Root cause investigation and resolution of complex manufacturing issues

    • CDMO performance recovery strategy and execution

    • Deviation and CAPA strategy and execution

    • Supply stabilization and continuity strategy

    • Ongoing oversight, performance management, and stabilization tracking

    • Rapid stabilization of at-risk supply chains and manufacturing operations

Proven Commercialization Experience
Leadership supporting multiple pharmaceutical product launches and delivering reliable commercial supply.